Control of Neglected Tropical Diseases
We coordinate and support policies and strategies to enhance global access to interventions for the prevention, control, elimination and eradication of neglected tropical diseases, including some zoonotic diseases.

Partners and collaborating institutions

Chagas disease (American trypanosomiasis)

The planning and implementation of the activities of surveillance and control is run in close collaboration with the UNICEF-UNDP-World Bank-WHO Special Programme for research and training in Tropical Diseases (TDR) and a number of international organizations, research institutions, development agencies, non-governmental organizations and private companies.

Several foundations, universities and research institutions promote or implement basic and applied research on the parasite, the vector and the disease, with the support of WHO. Among others, they develop new drugs, tools to diagnose, or verify treatment response, or work on new methods for vector control

Partners and collaborating institutions:

  • Agence canadienne de développement international (ACDI), Canada
  • Agència Catalana de Cooperació per al Desenvolupament (ACCD), Spain
  • Agencia Española de Cooperación Internacional (AECI), Spain
  • American Red Cross, the USA
  • Barcelona Centre for International Health Research (CRESIB), Spain
  • Canadian International Development Agency (ACDI/CIDA)
  • Central Blood Institute: Blood Service Headquarters. Japanese Red Cross Society, Japan
  • Centers for Disease Control and Prevention - CDC, the USA
  • Centro de Investigación en Enfermedades Infecciosas, Pontificia Universidad Católica del Ecuador, Ecuador
  • Grupo de Didáctica de las Ciencias (GDC), Instituto de Física de Líquidos y Sistemas Biológicos (IFLYSIB), Universidad Nacional de la Plata, Argentina.
  • Centre for Tropical Diseases, Sacro Cuore Don Calabria Hospital, Italy
  • Centro de Estudios Parasitológicos y de Vectores (CEPAVE), Universidad Nacional de La Plata, Argentina
  • Centro de Investigaciones en Microbiología y Parasitología Tropical – CIMPAT, Colombia
  • Centro Nacional de Diagnóstico e Investigación de Endemo-epidemias (CeNDIE), ANLIS Dr. Carlos G. Malbrán, Argentina
  • Centro Nacional de Microbiología, Instituto de Salud Carlos III, Spain
  • Centro de Pesquisas René Rachou - Fiocruz, Brazil
  • Centro Regional de Investigaciones Científicas y Transferencia Tecnológica (CRILAR), Argentina
  • Drugs for Neglected Disease initiative (DNDi)
  • Escola de Farmácia, Federal University of Ouro Preto, Brazil
  • European Community-Latin American Triatominae Network (ECLAT)
  • Facultad de Medicina, Universidad Mayor de San Simón, Bolivia
  • Faculdade de Medicina, Federal University of Minas Gerais, Brazil
  • Grupo de Estudos em Doença de Chagas (GEDoCh), Faculdade de Ciências Médicas, Universidade Estadual de Campinas (Unicamp)
  • Hospital das Clínicas, Universidade Federal de Goiás, Brazil
  • Infectious and Tropical Diseases Unit, Careggi Hospital, Florence, Italy
  • Institut de Recherche pour le développement (IRD)
  • Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud (inciensa), Costa Rica
  • Instituto de Diagnóstico y Referencia Epidemiológicos (InDRE), Centro Nacional de Vigilancia Epidemiológica y Control de Enfermedades (CENAVECE), México
  • Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Asunción, Paraguay
  • Instituto Nacional de Salud, Colombia
  • International Development Research Centre (IDRC), Canada
  • International Federation of Associations of People Affected by Chagas disease (FINDECHAGAS)
  • Japan International Cooperation Agency (JICA), Japan
  • Kids for world health, the USA
  • Laboratoire de Parasitologie. Université Libre de Bruxelles, Belgium
  • Laboratory of Applied Entomology and Parasitology (LENAP), School of Biology, Faculty of Chemical Sciences and Pharmacy, San Carlos University, Guatemala
  • Programa de Salut Internacional del Institut Català de la Salut - PROSICS, Spain
  • Tropical Medicine Institute of Sao Paulo, University of Sao Paulo, Brazil
  • Fundación Mundo Sano, Argentina
  • Grups de Recerca d'Amèrica i Àfrica Llatines (GRAAL), Facultat de Medicina, Universitat Autònoma de Barcelona (UAB), Spain
  • Hospital de Niños Dr. Ricardo Gutiérrez, Argentina
  • Institut de recherche pour le développement (IRD), France
  • Oswaldo Cruz Institute - Fiocruz, Brazil
  • Médecins Sans Frontières
  • Programa Nacional de Controle de Qualidade (PNCQ), Sociedade Brasileira de Análises Clínicas, Brazil
  • Service de Parasitologie-Mycologie. Groupe Hospitalier Pitié-Salpêtrière
  • University Hospital of Geneva, Switzerland
  • Universidad Santo Tomás, Chile

Private partners are companies concerned with the welfare and development of affected population and often offer equipment, material or drugs. They contribute in kind (drugs), coupled with financial support.

  • Bayer
  • Sanofi